Catch up on our webinar: 45% Faster Searches, Fewer Failed Experiments: A Data-Driven Approach to Antibody Selection
5
Min Read
In this blog:
- Gain practical insights into research antibody selection
- Learn more about the risks when this process goes wrong
- Hear from Dr Dres Damgaard, Principal Scientist at Novo Nordisk, for tips from the bench
October 23, 2026
Choosing the wrong antibody can waste weeks of work, cost thousands in budget and ultimately lead to a failed experiment. In this webinar, Dr Andrew Chalmers (CiteAb CEO and co-founder) and Dr Dres Damgaard (Principal Scientist, Novo Nordisk) discuss antibody selection in practice, drawing on Dres’ experience at the bench.
What you’ll learn:
- What data can help when selecting antibodies for your research
- Ways to save time when searching for research antibodies
- The risks to watch for when selecting antibodies
Dr Chalmers also gives a short demo of the CiteAb Explore platform for antibody selection, covering:
- Filtering your shortlist by validation method, recombinancy, and application
- Exploring published images and experimental data on product pages within CiteAb
Missed the webinar? You can catch up on the event below:
We put this event together to share data-driven strategies for searching and choosing antibodies to help reduce failed experiments and cut hours of manual searching. We hope you gain some valuable insights!
Skye is the Scientific Communications Manager at CiteAb, with a background in Biochemistry.
